SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024. Following the release, management will host a conference call and audio webcast to review results and provide a brief business and outlook update that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live c ...

Key PointsAugmedix uses ambient AI to transform doctor-patient conversations into structured medical notes, helping to improve workflows, reduce administrative burdens, and improve the accuracy of medical records.HCA Healthcare, the nation's largest for-profit hospital system, is a client and investor in Augmedix.Augmedix seeks to evolve the technology to serve as a change agent for organizations.5 stocks we like better than AugmedixAugmedix Inc. NASDAQ: AUGX is an artificial intelligence (AI) powered ambie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-40890 AUGMEDIX, INC. (Exact name of registrant as specified in its charter) | --- | --- | |---------------- ...

Augmedix, Inc. (NASDAQ:AUGX) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Matt Chesler - IR Manny Krakaris - CEO Paul Ginocchio - CFO Conference Call Participants Jared Haasec - William Blair Neil Chatterji - B. Riley Securities Allen Klee - Maxim Group LLC Aaron Wukmir - Lake Street Capital Markets Bill Sutherland - The Benchmark Company Pat Walravens - JMP Operator Greetings and welcome to Augmedix, Inc. 2023 Third Quarter Earnings Conference Call. [Operator Instructio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 83-3299164 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 111 Sutter Street, Suite 1300, San Francisco, California 94104 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (888) 669-4885 Title of each class Trading Symbol (s) Name on each exchange on which registered Common Stock, $0.0001 par value per share AUGX The Nasdaq ...

Augmedix, Inc. (NASDAQ:AUGX) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Matt Chesler - IR Manny Krakaris - CEO Paul Ginocchio - CFO Conference Call Participants Jared Haasec - William Blair Neil Chatterji - B. Riley Securities Aaron Wukmir - Lake Street Capital Markets Allen Klee - Maxim Group LLC Operator Ladies and gentlemen, greetings, and welcome to the Augmedix Inc. Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mod ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-40890 | --- | --- | |----------------------------------------------------------------------------|------------- ...

Investor Presentation May 2023 ...

Augmedix, Inc. (NASDAQ:AUGX) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company LLC Brooks O'Neil - Lake Street Capital Markets Allen Klee - Maxim Group Neil Chatterji - B. Riley Securities Operator Greetings, and welcome to the Augmedix Inc. First Quarter 2023 Earnings Conference Call. At this time, ...

Market Opportunity - The total addressable market in the United States for the company's services is approximately $6.0 billion annually, based on an average subscription price of $1,800 per clinician[30]. - Approximately 30% of the 980,000 physicians in the specialties served by the company are identified as the best prospects for utilizing its services[30]. - The company serves approximately 250,000 physicians through its existing enterprise customers, representing about 25% of the total U.S. addressable market[31]. - The company is exploring new products for nursing, which could further expand its total addressable market[31]. - The company plans to launch Augmedix Go in 2023, which will provide automated medical documentation based on recorded visits, expanding its addressable market[45]. Productivity and Efficiency - The company estimates that its products save clinicians up to two to three hours each day, allowing them to see more patients and improve work-life balance[22]. - The economic benefit from productivity gains is significant, with an estimated $4.12 million of net revenue generated over a 12-month period for a cohort of 100 physicians[35]. - The company's products can increase productivity by up to 20% and improve clinician satisfaction with work-life balance by 49%[34]. - The company reported delivering over 50,000 notes to customers each week during Q4 2022[22]. - The Augmedix Live product offers synchronous medical note documentation, with two-way interactivity, and is delivered via mobile devices, improving clinician workflow[42]. - The Augmedix Notes product provides asynchronous medical documentation, delivering notes within 4 hours or the next business day, depending on contract terms[44]. Customer Satisfaction and Retention - The company achieved a net revenue retention rate of 126% as of December 31, 2022, indicating strong customer satisfaction and loyalty[35]. - The company aims to reduce physician burnout by identifying those with documentation burdens and demonstrating the value of its services[50]. - Dr. Hengbing Wang reported a 15% increase in patient volume due to the support from Augmedix, allowing him to see urgent oncology referrals[76]. - Dr. Jacqueline Rohrer increased her patient load from 18 to 20 patients per day and reduced charting time from 2-3 hours to just 30-45 minutes[87]. Technology and Innovation - The Notebuilder Platform integrates AI technologies, including natural language processing and large language models, to automate medical note creation, enhancing efficiency[58]. - The technology platform is HIPAA compliant, ensuring data security and privacy for clinician-patient interactions[54]. - The Notebuilder Platform supports over 35 specialties and integrates with more than 50 EHRs, providing a competitive advantage in diverse care settings[40]. - The company has developed direct integration with major electronic health record (EHR) systems, enhancing operational efficiency and informing machine learning models for note documentation[112]. - The company has a patent portfolio consisting of five pending patent applications in the United States as of December 31, 2022, and continues to assess new intellectual property for protection[113]. Operations and Growth - The company operates ten MDS Operations Centers across four countries, with a strategy to diversify geographical risk[69]. - The Bangladesh operation is the largest and fastest growing center, serving about 38% of clinicians as of December 31, 2022, with expectations to exceed 40% by the end of 2023[70]. - Approximately 80% of the physicians served are members of large health systems, with one client accounting for 14% of clinicians in service[74]. - The primary care specialty accounts for 41% of total physicians served, with the top four EHR systems (Epic, Cerner, iKnowMed, APeX) representing 76% of all physicians served[74]. - The company is focused on expanding relationships with existing customers and targeting new health systems and large physician groups to drive growth[51]. Compliance and Security - The healthcare industry is highly regulated, with compliance required for various laws including HIPAA and the False Claims Act, which can lead to substantial penalties for violations[89]. - The company has implemented safeguards to address the privacy and security of protected health information (PHI) in compliance with HIPAA and HITECH regulations, which could impose civil fines and criminal sanctions for non-compliance[99]. Workforce and Training - As of December 31, 2022, the company had a total of 1,040 employees, with 268 in the United States, 42 in India, and 730 in Bangladesh[119]. - The training program for new MDSs takes approximately three months to complete, including strict testing and grade achievement standards[67]. - MDS Vendors are currently paid based on an hourly rate reflecting the amortized cost of training and certifications, a change from the previous model that included upfront flat fees[71]. Marketing and Sales - The company signed a marketing partnership with Google in 2022, resulting in the acquisition of two new health systems, including one of the ten largest health systems in the US[105]. - The company primarily relies on a dedicated direct sales force and customer success team to drive sales, with a typical implementation window of 30-45 days from contract execution to service commencement[103]. - The company utilizes various marketing strategies, including search engine optimization and social media campaigns, to generate leads and build market awareness[104]. - The company is continuously improving its streaming platform to enhance audio quality and user experience while reducing costs[107]. Hardware Transition - Approximately 5% of clinicians currently use Google Glass, which is being phased out, prompting a transition to alternative hardware solutions[110].